F-star Therapeutics FSTX
$ 7.12
0.0%
Quarterly report 2022-Q3
added 11-10-2022
F-star Therapeutics Financial Ratios 2011-2024 | FSTX
Annual Financial Ratios F-star Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -3.0 | - | - | - | - | - | - | - | - | - |
P/S |
2.4 | 6.8 | - | - | - | - | - | - | - | - | - |
EPS |
-1.9 | -9.7 | -1.5 | -1.6 | -2.5 | -2.4 | -2.0 | - | - | - | - |
EV (Enterprise Value) |
-2.44 M | 78.5 M | 1.23 M | -14.7 M | -23.6 M | -10.7 M | -4.35 M | - | - | - | - |
EBITDA per Share |
-1.81 | -2.34 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.1 | -2.7 | - | - | - | - | - | - | - | - | - |
PEG |
- | 0.26 | - | - | - | - | - | - | - | - | - |
P/B |
0.5 | 1.8 | - | - | - | - | - | - | - | - | - |
P/CF |
-1.8 | -4.5 | - | - | - | - | - | - | - | - | - |
ROE % |
-32.30 | -59.59 | - | - | - | - | - | - | - | - | - |
ROA % |
-25.43 | -40.28 | - | - | - | - | - | - | - | - | - |
ROCE % |
-31.71 | -48.00 | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.7 | 1.5 | - | - | - | - | - | - | - | - | - |
DSO |
- | 129.9 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios F-star Therapeutics
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.84 | -0.88 | -0.57 | - | -0.52 | -0.91 | -1.07 | - | -1.88 | -3.53 | -3.92 | - | -0.42 | -0.28 | -0.32 | - | -0.59 | -0.29 | -0.37 | - | -0.85 | -0.93 | -0.69 | - | -0.53 | -0.62 | -1.11 | - | -0.59 | -0.39 | -0.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.61 | -0.74 | -0.52 | - | -0.44 | -0.85 | -1.15 | - | -1.8 | -2.56 | -2.81 | - | -0.45 | -0.58 | -0.5 | - | -0.51 | -0.6 | -0.47 | - | -0.41 | -0.55 | -0.48 | - | -0.53 | -0.62 | -1.11 | - | -0.58 | -0.39 | -0.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-72.55 | -84.53 | -64.18 | -53.29 | -55.43 | -63.46 | -59.51 | -58.92 | -39.71 | -59.16 | -70.59 | -68.39 | -46.90 | -62.62 | -58.88 | -52.83 | -31.20 | -62.36 | -77.81 | -96.61 | -75.45 | -99.82 | -93.04 | -92.73 | -87.95 | -118.76 | -125.20 | -120.45 | -69.10 | -69.10 | -38.29 | -17.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-51.40 | -60.80 | -48.21 | -41.74 | -40.02 | -45.44 | -41.47 | -39.23 | -26.84 | -37.78 | -43.29 | -40.34 | -26.37 | -39.12 | -40.95 | -39.24 | -25.33 | -46.02 | -53.94 | -65.43 | -50.09 | -65.52 | -60.27 | -59.28 | -55.68 | -78.99 | -86.86 | -86.38 | -52.26 | -52.26 | -28.96 | -13.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-59.35 | -70.01 | -56.59 | -48.91 | -56.00 | -63.88 | -61.10 | -57.32 | -31.18 | -52.22 | -65.39 | -81.74 | -72.11 | -85.92 | -78.69 | -65.44 | -39.15 | -54.08 | -55.20 | -56.10 | -43.06 | -67.59 | -77.19 | -87.45 | -88.33 | -119.23 | -125.60 | -120.78 | -69.23 | -69.23 | -38.33 | -17.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 3.1 | 3.5 | 4.3 | 4.7 | 4.6 | 4.8 | 2.9 | 3.1 | 3.1 | 3.1 | 3.1 | 1.3 | 2.3 | 2.3 | 2.3 | 5.3 | 5.3 | 5.3 | 5.3 | 3.0 | 3.0 | 3.0 | 3.0 | 2.7 | 2.7 | 2.7 | 2.7 | 4.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | 43.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | 43.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | 43.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency